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Abstract    
Objective: To compare early operative treatment with non-operative treatment of fragility 
fractures of the pelvis regarding mortality and functional outcome. 
Design: Retrospective 
Setting: Two trauma centers 
Patients and Methods: 230 consecutive patients 60 years of age or older with an isolated 
low-energy fracture of the pelvis and with a follow-up of at least 24 months. In center 1, 
treatment consisted of a non-operative attempt and early operative fixation if mobilization 
was not possible. In center 2, all patients were treated non-operatively.  
Main Outcome Measurements: Primary outcome was mortality. Secondary outcomes were 
in-hospital complications. Patients that survived were contacted by phone and a modified 
Majeed Score was obtained to assess functional outcome at final follow-up 
Results: At final follow-up (mean 61 months, SD 24), 105/230 (45.7 %) patients had died. 
One year after the initial hospitalization 34/148 patients (23%, 95% CI: 17% to 31%) of the 
ear1y operative group and 14/82 patients (17%, 95% CI 10% to 27%) of the non-operative 
group had died (p=0.294). Non-operative treatment had a protective effect on survival during 
the first two years (hazard ratio of the non-linear effect: 2.86, 95% CI 1.38 to 5.94, p<0.001). 
Patients in the early operative treatment group who survived the first two years, had a better 
long-term survival. The functional outcome at the end of follow-up as measured by a 
modified Majeed score was not different between the two groups (early operative: 66.1, SD 
12.6 vs. non-operative: 65.7, SD 12.5, p=0.910). 
Conclusion:  
Early operative fixation of patients who cannot be mobilized within three to five days was 
associated a higher mortality rate and complication rate at 1 year but with a better long-term 
survival after more than two years. Hence, patients with a life expectancy of less than 2 years 
may not benefit from surgery with regard to survival. 
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Level of Evidence: III 
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Introduction 
Fragility fractures of the pelvis (FFP) have had an increased incidence within the 
geriatric population. They frequently are a result of a low energy trauma in the presence of 
osteoporosis 1. The mean cumulative risk of sustaining a pelvis fracture between the age of 65 
and 90 years is 6.9 % in women and 2.8 % in men. It is likely that the incidence of FFPs will 
triple during the next 20 years 2,3.  
Most of these fractures are stable and can be successfully treated by non-operative 
treatment 4. However, all-cause mortality and in-hospital complications reported for non-
operative treatment of FFP can be as high as from hip fractures 5–7. Hence, especially 
percutaneous surgical techniques have been suggested as a valuable alternative to non-
operative treatment 8–10. Operative treatment is thought to reduce pain and to facilitate 
mobilization in patients with FFPs 11,12. Even though complications and overall mortality 
remain high among geriatric patients with a FFP when treated operatively 13, a benefit of 
surgical over non-operative treatment with regard to mortality has been suggested 14. 
However, most studies on this topic did not account for the selection bias frequently seen with 
comparisons of operative and non-operative treatment in elderly patients: it is often the 
patients’ morbidity that triggers the decision for non-operative treatment and not the other 
way around. 
The aim of this study was to compare non-operative treatment to early operative 
intervention with respect to mortality and functional outcome. Our hypothesis was that early 
operative fixation of patients who cannot be mobilized within three to five days would have a 
beneficial effect on survival.  
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Materials and Methods 
Patients 
This retrospective multicenter propensity matched case-control study with a 
prospective follow-up was approved by the local ethics committee (Kantonale 
Ethikkommission Zürich, Switzerland. KEK-ZH-Nr. 2017-01440).  
Based on previous studies we estimated the 1-year mortality in the non-operative 
group to be around 24 %  15. Assuming a decrease in 1-year mortality down to 15 % and 
aiming for an 80% power one would need to include 237 patients in the study.  
 391 consecutive patients  60 years of age or older who were treated for a low-energy 
fracture in one of the two study centers between 01/2008 and 12/2015 were evaluated. 
Patients who had concomitant fractures of the acetabulum or the lower extremity, who were 
not included by the national social insurance mortality database (e.g. tourists) or who had 
expressed objection to the use of their data for research purposes were excluded (Patient flow 
chart, Figure 1). In addition, patients who were by language or cognitive impairment not able 
to understand the Majeed questionnaire were excluded from the functional outcome 
assessment. All patients evaluated required a minimum of 24 months follow-up. 
 
Intervention 
 Two treatment concepts were compared: In center 1 (early operative group), treatment 
consisted of an initial non-operative attempt including analgesic medication including opioids 
and physiotherapy without weight-bearing restrictions. If patients were not able to ambulate 
with a walker or crutches under analgesic medication within three to five days, early operative 
fixation was performed. As a standard, sacral fractures were addressed by percutaneous sacro-
iliac screw fixation, if possible in S1 and S2 (6.5-cannulated steel screws) 9,10. In case of 
bilateral sacral fractures, bilateral sacro-iliac screws were placed in S1 and S2 or spino-pelvic 
posterior instrumentation was performed. If displaced more than a shaft width or if the patient 
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reported localized inguinal pain, anterior ring fractures were stabilized by either plate or 
ramus screw fixation and in case of comminution of the anterior pelvic ring a subcutaneous 
internal anterior fixation (INFIX) was used. Open reduction and plate fixation was reserved 
for fractures with gross displacement. 
In center 2 (non-operative group), all patients were treated non-operatively by means 
of analgesic therapy including opioids and physiotherapy. This regimen mainly included an 
early mobilization accompanied and carefully instructed by the physiotherapist. Full weight 
bearing was never restricted. Depending on the level of pain, mobilization was initiated with a 
walker and advanced to crutches or cane.  Whenever possible, patients were also mobilized on 
an anti-gravity treadmill (AlterG, Fremont, CA, USA) for 30 minutes per day.   
 
Outcome 
 Primary outcome was mortality. In addition to a time-to-event approach of mortality at 
last follow-up, 1-year and 2-year mortality were assessed. Survival status was retrieved from 
a national social insurance mortality database (Alters- und Hinterlassenen-Versicherung) that 
provides survival data for each permanent resident in Switzerland. 
Secondary outcomes were in-hospital complications including hospital-acquired 
infections (e.g. pneumonia and urinary tract infections), thromboembolic events, 
postoperative delirium and duration of the hospitalization. Those patients that had survived 
were contacted by phone and a modified Majeed Score was obtained to assess functional 
outcome at final follow-up 13,16,17.  
 
Statistical Analysis 
Statistical analysis was performed with R for windows 3.5.0 18. Descriptive statistics 
included mean and standard deviation (SD) for the continuous variables, median and 
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interquartile range (IQR) for ordinal variables, as well as number and percentage of total for 
the categorical variables.  
Kaplan-Meier plots were used to visualize the survival probability in both treatment 
groups. Median survival and median follow-up times were displayed including 95% 
confidence intervals (CI). If Kaplan-Meier curves crossed, time-varying treatment effects 
were assumed. To quantify the effect of the non-operative treatment, Cox proportional hazard 
models were fitted. Time-varying treatment effects of non-operative treatment were assumed 
to be non-linear over time, g(t) = log(t+1). The treatment regime might have been influenced 
by factors such as age, gender, or American Society of Anesthesiologists Classification 
(ASA) 19, therefore these variables were accounted for in the analysis through the estimation 
of a propensity score. Propensity score matching is a statistical technique that tries to estimate 
the effect of an intervention by accounting for covariates that may predict receiving the 
treatment. This is done by adjusting for potential confounders that were found by simply 
comparing outcomes among patients that received the treatment versus those that did not. 
In a first approach, the treatment effect was estimated without any adjustment for 
confounding. In a second approach, the propensity score was used to adjust for confounding 
in the Cox model, in a third approach the propensity score was used for matching each patient 
with early operative treatment to a patient with non-operative treatment. Balance after 
matching was assessed using the standardized mean difference (SMD). The SMD is a 
statistical parameter measuring effect sizes and is defined as the mean divided by the standard 
deviation of a difference between two random values each from one of two groups. If the 
SMD is < 0.1, the variable can be considered balanced across treatment groups 20. 
Results of the Cox models are presented graphically, with estimated hazard ratios, 
95% CIs, and p-values. Missing data were reported as such for each outcome parameter.  
The study was reported according to the STROBE guidelines for observational studies. 
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Results 
In total, 230 patients with a mean age of mean 81 years (range, 60 to 98 years) were 
included in the final analysis (Patient flow chart, Figure 1). Of the 230 patients, 148 patients 
were included in the early-operative group and 82 in the non-operative treatment group. Early 
operative fixation was performed in 60/148 (41%) of the patients in the early operative 
treatment group, for the rest the initial non-operative attempt was successful and continued. 
Of the 60 patients eventually treated by operative fixation, 33 received unilateral percutaneous 
sacro-iliac screw fixation and 24 bilateral sacro-iliac screw fixation. Two patients were 
stabilized by posterior spino-pelvic instrumentation and two by posterior plate fixation. The 
anteriopr pelvic ring was stabilized by plate fixation through a modified Stoppa approach in 8 
cases, by ramus screws in 5 cases, and by an INFIX in 4 cases. Most of the patients in both 
groups were female (81% and 89%, respectively). Forty-four percent of the patients in the 
non-operative and 52 % of the early-operative had an ASA score greater than 3 (p=0.297, 
Table 1).  
 The median follow-up time was longer for patients in the early operative group (69 
months, 95%CI: 60 to 85 months) than for patients in the non-operative group (44 months, 
95% CI: 41 to 53 months). 
 
Unadjusted comparison of secondary outcomes 
Patients in the early-operative group were hospitalized for mean 12 days (SD 9) 
compared to the non-operative group with 8 days (SD 4, p<0.001). Thirty-six of 148 patients 
in the early-operative group (24%) and 19 (23%) in the non-operative group were able to 
return to home.  
Complications during the hospitalization were more likely to occur in the early 
operative group compared to the non-operative group (p=0.005, Table 2).  
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Mortality 
 At final follow-up (mean 61 months, SD 24), 105/230 (45.7 %) patients had died.  
One year after the initial hospitalization 34/148 patients (23%, 95% CI: 17% to 31%) of the 
early operative group and 14/82 patients (17%, 95% CI 10% to 27%) of the non-operative 
group had died (p=0.294).  
 Kaplan-Meier analysis of the unadjusted survival status in the early operative and the 
non-operative treatment group showed a crossing of the survival curves at two years (Figure 
2).  
 Hence, the time varying treatment effect was calculated in three different ways: without 
adjustment, with propensity-score adjustment and with matching. The matched sets of 
patients were balanced with respect to SMD (SMD < 0.1). Details can be found in Table 1, 
Figure 3 shows the estimated treatment effects for non-operative treatment. 
 Non-operative treatment was associated with better survival during the first two years. 
However, patients in the early operative treatment group who survived the first two years, had 
a better long-term survival. This means that survival was better in the non-operative group 
during the first two years and worse after that. 
 
Functional outcome 
 To determine the functional outcome at final follow-up up (mean 61 months, SD 24), a 
modified Majeed score was used (maximum achievable points was 76). Forty (27%) of the 
patients with early operative treatment and 15 (18%) of the patients with non-operative 
treatment were available for final follow-up assessment of the Majeed score. On average, the 
Majeed score was 66.1, SD 12.6 (87 % of achievable maximum) for the early operative group 
and 65.7, SD 12.5 (86 % of achievable maximum) for the non-operative group (p=0.910). 
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Discussion 
The aim of this study was to compare non-operative treatment of FFPs to early 
operative intervention with respect to mortality and functional outcome. Our hypothesis, that 
early operative fixation of patients who cannot be mobilized within three to five days would 
have a beneficial effect on 1-year survival was not confirmed. The survival rates were similar 
during the first two years. However, in those patients who survived the first two years, early 
operative treatment was associated with a better long-term survival. In those patients 
surviving, no difference in functional outcome was seen at final follow-up. 
This study compared all-cause mortality rates of geriatric patients with FFPs over a 
period of more than 3 years. There are numerous factors that can have influence on the 
survival of such patients, in particular at this age and with the number of comorbidities known 
to be associated with fragility fractures 21. There are few things, though, that have more 
impact on disability, morbidity and mortality of elderly patients as the ability to walk 22.  
A therapy that could reduce pain after FFPs, accelerate mobilization and improve gait 
would therefore have a major beneficial effect on survival. Indeed, and in line with previous 
studies this study found a better survival in operatively treated patients in the long run 14. 
However, the mortality in the early operative group remained high within the first two years 
and was even higher when compared to the non-operative group.  
Previous studies on non-operative treatment of pelvis fractures report mortality rates 
of 13 % at 3 months 6 and 54 % at 5 years 7. These numbers are consistent with the findings of 
our study.  The higher mortality in the early operative group may be explained by 
perioperative risks associated with anesthesia and surgery in elderly people. In line with this, 
52 % of the early-operative group had an ASA score greater than 3. Still, the 2-year mortality 
was higher than described by Höch et al. for their cohort of operatively treated patients with 
FFP (Höch et al. 2017). However, this study is the first one with a 100 % follow-up for 
mortality data as we had access to the complete national social insurance mortality database. 
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The limitations of this study are inherent with its retrospective study design. Hence, it 
mainly reports associations and not necessarily causations. It was sought to compensate for 
this by adjusting for potential confounders as age, gender and prevalent morbidity by 
conducting a propensity score matched analysis. The ASA classification may be an imprecise 
instrument to fully depict a patient’s comorbidities. It is a very well validated instrument to 
predict perioperative mortality, however 19. Hence, it was chosen as a surrogate parameter for 
matching. However, the crossing of survival curves indicating better survival of the early 
operative group after more than two years could be a result of other confounding factors that 
we did not account for. It, still, may be that the perioperative and delayed complications after 
operative treatment have a longer-lasting effect that is being overcome by the benefits of 
better mobility only after two years. 
The effect of operative stabilization may be small but relevant in the long run. An 
increased risk for falling or even just a decreased gait speed due to sacral pain are known to 
be associated with a higher mortality 22. This may have an impact on mortality even after two 
years. 
As frequently seen in studies on geriatric populations, the follow-up rate of the 
functional outcome was low - in part due to the fact that 45.7 % of the patients had deceased 
at the time of final follow-up. This limits our conclusions on functional outcome. The primary 
outcome of this study, however, was not functional outcome but survival. For the mortality 
data we could provide a 100 % follow-up as we had access the national social insurance data. 
We also did not assess the effect of the two treatment concepts on early functional outcome 
and pain nor on quality of life. The quality of any treatment algorithm must be judged by 
parameters beyond mortality and complications only. The results of this study justify future 
prospective comparative trials in order to confirm the long-term effect of early operative 
fixation of FFPs.  
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Conclusion 
Early operative fixation of patients who cannot be mobilized within three to five days 
was associated a higher mortality rate and complication rate at 1 year but with a better long-
term survival after more than two years. Hence, patients with a life expectancy of less than 2 
years may not benefit from surgery with regard to survival. 
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Figure legends 
 
Figure 1 Patient flow chart 
 
Figure 2 Kaplan Meier plots of survival probabilities in patients with early operative 
and non-operative treatment regime.  
Number at risk are given for both groups. Time is measured in years. 
 
Figure 3 Time-varying treatment effect of non-operative treatment.  
Black solid line represents the unadjusted treatment effect, dotted line indicates the 
propensity-score adjusted treatment effect, and the dashed line represents the time-varying 
effect estimated from the 82 pairs of matched patients with early operative and non-operative 
treatment. The hazard ratio of the non-linear effect was 2.86 (95% CI 1.38 to 5.94, p<0.001). 
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Table 1 Baseline characteristics 
Before matching After matching1) 
Early operative Non-operative p Early operative Non-operative SMD2) 
n 
 
148 
 
82 
 
82 
 
82 
 
Age (mean, SD) 79.66 (9.25) 84.43 (6.20) <0.001 84.77 (5.93) 84.43 (6.20) 0.056 
Gender female, n (%)   120 (81.1)     73 (89.0)  0.167    71 (86.6)     73 (89.0)  0.075 
ASA (median, interquartile range) 3 [2, 3] 2 [2, 3] 0.165 
ASA ≥ 3, n (%)    77 (52.0)     36 (43.9)  0.297    40 (48.8)     36 (43.9)  0.098 
 
1) Propensity score-matched for age, gender, ASA ≥ 3; 2) SMD = standardized mean difference, if < 0.1 variables are assumed balanced. 
 
 
Table 2 Secondary outcomes  
Early operative Non-operative p 
n 148 82 
Inhospital complications, n (%) 51 (34.5) 14 (17.1) 0.008 
  Infection, n (%) 37 (25.0) 11 (13.4) 0.057 
  Thromboembilic event, n (%) 3 (2.0) 0 (0.0) 0.49 
  Delirium, n (%) 14 (9.5) 1 (1.2) 0.032 
  Death, n (%) 6 (4.1) 2 (2.4) 0.791 
 
Mod. Majeed score (mean, SD) 66.1 (12.6) 65.7 (12.5) 0.91 
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